FutureTech II Acquisition Corp. (FTII) to Combine with Longevity Biomedical in $100M Deal

FutureTech II (NASDAQ:FTII) has entered into a definitive agreement to combine with Longevity Biomedical at a pre-money valuation of $100 million. Bothell, Washington-based Longevity is building a platform to consolidate a number of clinical-stage therapies, beginning with treatment candidates aiming to improve outcomes of certain vascular conditions as well as replace lost tissue. The combined
Read More